Selected clinical and demographic factors and all-cause mortality among individuals with Duchenne muscular dystrophy in the Muscular Dystrophy Surveillance, Tracking, and Research Network

•Estimated 50% survival until age 23.7 years and 12.5 years after loss of ambulation•After loss of ambulation, glucocorticoid users had lower risk of death than non-users•Lower risk of death observed among ever-users of cough assist and scoliosis surgery•Non-Hispanic Black males had higher risk of death than Non-Hispanic White males•Cardiac medication and bilevel positive airway pressure were not associated with death